Final Title X Regulation Changes, Implications and What’s Ahead
On Monday, March 4, 2019, the Trump Administration published final regulations for the federal Title X family planning program that could dramatically reshape the safety-net program.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
On Monday, March 4, 2019, the Trump Administration published final regulations for the federal Title X family planning program that could dramatically reshape the safety-net program.
This brief explains the contraceptive coverage rule under the ACA, the impact it has had on coverage, and how the new regulations issued by the Trump administration have changed the contraceptive coverage requirement for employers with religious and moral objections to contraception and the women who receive coverage through their plans.
The Affordable Care Act (ACA) requires employers to cover the full cost of prescription birth control as part of their health insurance plans. The June Kaiser Health Tracking Poll finds that a majority of the public support the requirement for private health insurance plans to cover the full cost of birth control. This includes a majority of Democrats, independents, and Republicans.
In October 2023, the Departments of the Treasury, Labor, and Health and Human Services issued a request for information to gather public input about the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover OTC preventive services and supplies without a prescription. This policy watch addresses key considerations for the implementation of insurance coverage for non-prescribed OTC contraceptives based on the lessons learned from KFF’s 2023 study of Insurance Coverage of OTC Oral Contraceptives.
This brief provides an overview of oral contraception, discusses private insurance and Medicaid coverage, and reviews strategies to promote and expand women’s access to oral contraceptives.
This analysis provides data on women experiencing intimate partner violence (IPV) and reports on a range of health topics affecting women who experienced IPV in the past five years, including their health care needs and use, barriers, and mental health.
This brief provides an overview of the most recent ACA case under review at the Supreme Court (Kennedy v. Braidwood Management) and discusses the implications of the potential rulings by the high court.
This brief examines pregnancy loss management in the Dobbs era and explores how limiting or banning abortion may have negative consequences on people experiencing miscarriage or stillbirth.
This brief describes Medicare coverage of sexual and reproductive health services, including contraception, and compares that coverage with private insurance plans and Medicaid. These benefits are particularly relevant to nearly 1 million women of reproductive age (20-49) who are eligible for Medicare due to having a long-term disability.
This report provides an analysis of donor government funding to address family planning in low- and middle-income countries in 2022, which totaled US$1.35 billion and was a decline of 9% (US$129 million) compared to the 2021 amount (US$1.48 billion). While the decline was due to decreases in funding by most donor governments, a significant share can be attributed to exchange rate fluctuations resulting from the rise in value of the U.S. dollar against most currencies during 2022.
© 2025 KFF